Slate Bio Overview
- Year Founded
-
2020
- Status
-
Private
- Employees
-
5
- Latest Deal Type
-
Later Stage VC
- Latest Deal Amount
-
$150K
- Investors
-
8
Slate Bio General Information
Description
Developer of a therapeutic platform intended to offer immunotherapeutics to resist autoimmune and inflammatory diseases. The company creates therapies that restore the body's natural immunological response in various diseases using bifunctional cytokines, enabling patients a second independent synergistic pathway that has tissue selectivity and improved pharmacodynamics, at lower doses and without side effects.
Contact Information
Website
www.slatebio.comCorporate Office
- 310 2nd Street Southeast
- Suite B
- Charlottesville, VA 22902
- United States
Corporate Office
- 310 2nd Street Southeast
- Suite B
- Charlottesville, VA 22902
- United States
Slate Bio Timeline
Slate Bio Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. Later Stage VC | 01-Aug-2026 | $150K | Completed | Generating Revenue | ||
| 5. Early Stage VC | 01-Jun-2024 | Completed | Generating Revenue | |||
| 4. Seed Round | 24-May-2023 | Completed | Pre-Clinical Trials | |||
| 3. Seed Round | 20-Dec-2021 | Completed | Pre-Clinical Trials | |||
| 2. Seed Round | 19-Jan-2021 | $2M | $2M | Completed | Startup | |
| 1. University Spin-Out | 15-Sep-2020 | Completed | Startup |
Slate Bio Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Seed-1 | ||||||||
| Seed |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Slate Bio Comparisons
Industry
Financing
Details
Slate Bio Competitors (2)
One of Slate Bio’s 2 competitors is Xenetic Biosciences, a Corporation company based in Framingham, MA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Xenetic Biosciences | Corporation | Framingham, MA | ||||
| TScan Therapeutics | Formerly VC-backed | Waltham, MA |
Slate Bio Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Slate Bio Patents
Slate Bio Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2024381770-A1 | Bifunctional il-2 and il-33 proteins for treating autoimmune disease | Pending | 15-Nov-2023 | ||
| EP-4808955-A1 | Bifunctional il-2 and il-33 proteins for treating autoimmune disease | Pending | 15-Nov-2023 | ||
| WO-2025106677-A1 | Bifunctional il-2 and il-33 proteins for treating autoimmune disease | Inactive | 15-Nov-2023 | ||
| WO-2025106685-A1 | Interleukin-2 superkine and interleukin-33, compositions and uses thereof | Inactive | 15-Nov-2023 | ||
| US-20260265325-A1 | Interleukin-33 variants, compositions and uses thereof | Pending | 15-Nov-2023 | C07K14/54 |
Slate Bio Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Slate Bio Investors (8)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Virginia Innovation Partnership Corporation | Not-For-Profit Venture Capital | Minority | ||
| CAV Angels | Angel Group | Minority | ||
| Epidarex Capital | Venture Capital | Minority | ||
| PharmaDirections | Corporation | Minority | ||
| UVA LVG Seed Fund | Venture Capital | Minority |
Slate Bio FAQs
-
When was Slate Bio founded?
Slate Bio was founded in 2020.
-
Where is Slate Bio headquartered?
Slate Bio is headquartered in Charlottesville, VA.
-
What is the size of Slate Bio?
Slate Bio has 5 total employees.
-
What industry is Slate Bio in?
Slate Bio’s primary industry is Drug Discovery.
-
Is Slate Bio a private or public company?
Slate Bio is a Private company.
-
What is Slate Bio’s current revenue?
The current revenue for Slate Bio is .
-
How much funding has Slate Bio raised over time?
Slate Bio has raised $6.03M.
-
Who are Slate Bio’s investors?
Virginia Innovation Partnership Corporation, CAV Angels, Epidarex Capital, PharmaDirections, and UVA LVG Seed Fund are 5 of 8 investors who have invested in Slate Bio.
-
Who are Slate Bio’s competitors?
Xenetic Biosciences and TScan Therapeutics are competitors of Slate Bio.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
